Entrada Therapeutics (TRDA) AGM 2026 summary

Opening remarks and agenda

• The virtual annual meeting was called to order by the CEO and Chairman, with stockholders and visitors welcomed and informed of the meeting's recording and participation procedures.

• The agenda included formal business as described in the proxy statement, with questions limited to official business and only validated stockholders allowed to participate.

Board and executive committee updates

• Current board members and executive officers were introduced, including directors and key officers present via webcast.

• Representatives from the independent accounting firm and outside counsel were also present.

Corporate governance

• The Inspector of Election was appointed and sworn in to oversee and tabulate voting results.

• A quorum was confirmed with 33,190,234 shares represented out of 38,820,616 entitled to vote.

• Voting procedures were explained, with polls opened and closed during the meeting.